Concepedia

Wen‐I Wu

WW

31

Publications

2.7K

Citations

27

H-Index

1992

Active since

Affiliations

Rutgers, The State University of New Jersey(Current)

University of Colorado Denver

Array BioPharma (United States)

National Jewish Health

McMaster University

Wen‐I Wu is an author at Rutgers, The State University of New Jersey specializing in medicine, natural sciences, and biochemistry.

ORCID

Top concepts

Publications per year

1992–2024

31

Publications

31

A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors

Alexander Drilon, Ramamoorthy Nagasubramanian, James F. Blake et al. · Cancer Discovery · 2017 · 419 citations · Full text

Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition

Wen‐I Wu, W.C. Voegtli, Hillary L. Sturgis et al. · PLoS ONE · 2010 · 319 citations · Full text

, , +19

An ATP-Site On-Off Switch That Restricts Phosphatase Accessibility of Akt

Kui Lin, Jie Lin, Wen‐I Wu et al. · Science Signaling · 2012 · 166 citations

, , +16

Plants Synthesize Ethanolamine by Direct Decarboxylation of Serine Using a Pyridoxal Phosphate Enzyme

Denis Rontein, Ikuo Nishida, Gen Tashiro et al. · Journal of Biological Chemistry · 2001 · 159 citations · Full text

Disruption of PH–kinase domain interactions leads to oncogenic activation of AKT in human cancers

Chaitali Parikh, Vasantharajan Janakiraman, Wen‐I Wu et al. · Proceedings of the National Academy of Sciences · 2012 · 148 citations · Full text

Rows per page

1–5 of 31